Woodford Investment Management Founded 2014
Founders
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 25
Average round size
info
The average size of a deal this fund participated in
$52M
Portfolio companies 25
Rounds per year 3.57
Lead investments 9
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.26
Exits -
Key employees -
Stages of investment
Early Stage Venture
Private Equity
Areas of investment
Finance
Financial Services
Summary

In 2014 was created Woodford Investment Management, which is appeared as Corporate Investor. The company was established in Europe in United Kingdom. The main office of represented Corporate Investor is situated in the Oxford.

We also calculated 1 valuable employee in our database.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Woodford Investment Management, startups are often financed by Invesco, Lansdowne Partners, Allied Minds. The meaningful sponsors for the fund in investment in the same round are Imperial Innovations, Lansdowne Partners, Invesco. In the next rounds fund is usually obtained by Dolby Family Ventures, Lansdowne Partners, Invesco Perpetual.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are Therapeutics, Electronics. Among the most popular portfolio startups of the fund, we may highlight benevolent.ai, Oxford Nanopore Technologies, Atom Bank.

Considering the real fund results, this Corporate Investor is 23 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2015. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2016. The average startup value when the investment from Woodford Investment Management is 100-500 millions dollars. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Woodford Investment Management performs on 16 percentage points less the average number of lead investments. The fund is generally included in 2-6 deals every year.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Econic Technologies
Chemical
Manufacturing
Plastics and Rubber Manufacturing
Waste Management
Venture - Series Unknown
5M06 Jul 2016 United Kingdom, Westminster
Inivata
Biotechnology
Genetics
Health Care
Medical Device
Series A
31M26 Jan 2016 United Kingdom, Cambridge
Metalysis
3D Printing
Advanced Materials
Aerospace
Automotive
Industrial
Manufacturing
Mining Technology
Venture - Series Unknown
16M28 Mar 2018 United Kingdom, Rotherham
Immunocore
Biotechnology
Medical
Pharmaceutical
Series A
320M16 Jul 2015 United Kingdom, Vale of White Horse
Kuur Therapeutics
Biotechnology
Health Care
Medical
Series B
68M25 Nov 2014 United Kingdom, Westminster
Nexeon
Battery
Electronics
Hardware
Private Equity
41M09 May 2016 United Kingdom, Vale of White Horse
Econic Technologies
Chemical
Manufacturing
Plastics and Rubber Manufacturing
Waste Management
Venture - Series Unknown
9M21 Feb 2018 United Kingdom, Westminster
Inivata
Biotechnology
Genetics
Health Care
Medical Device
Series B
52M28 Mar 2019 United Kingdom, Cambridge
Psioxus Therapeutics
Biotechnology
Health Care
Therapeutics
Series C
34M19 May 2015 United Kingdom, Vale of White Horse
Autolus
Biopharma
Biotechnology
Medical
Pharmaceutical
Series C
80M26 Sep 2017 United Kingdom, Westminster
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Woodford Investment Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: